Insider Transactions in Q1 2018 at Crispr Therapeutics Ag (CRSP)
Insider Transaction List (Q1 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 16
2018
|
Tyler Dylan Hyde Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
66,000
-37.48%
|
$1,848,000
$28.11 P/Share
|
|
Jan 16
2018
|
Tyler Dylan Hyde Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,000
+17.33%
|
$252,000
$12.57 P/Share
|
|
Jan 05
2018
|
Aktiengesellschaft Bayer > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
527,472
+8.56%
|
$11,604,384
$22.75 P/Share
|
|
Jan 05
2018
|
Kurt Von Emster Director |
BUY
Open market or private purchase
|
Indirect |
65,934
+3.38%
|
$1,450,548
$22.75 P/Share
|
|
Jan 05
2018
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
92,337
-4.83%
|
$2,400,762
$26.96 P/Share
|
|
Jan 02
2018
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
37,754
-1.93%
|
$981,604
$26.76 P/Share
|
|
Jan 02
2018
|
Tyler Dylan Hyde Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
38,000
-20.08%
|
$874,000
$23.15 P/Share
|
|
Jan 02
2018
|
Tyler Dylan Hyde Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+9.28%
|
$96,000
$12.57 P/Share
|